Build your career discovering therapies that will transform the lives of millions.
NF1 is the most common rare disease, but it has been surprisingly overlooked by researchers – until now. NTAP is leading the way in accelerating breakthrough research across oncology, dermatology, neurology and more. Delivering results that will benefit not only patients with NF1, but patients with all kinds of common tumors.
If there are no positions posted here, it means we have no open positions at this time. But you are still welcome to send us your resume, or apply for funding for an NF1-related research idea.